Phase 3 Study of Dexpramipexole in ALS

Clinical trial NCT01281189 · COMPLETED

Trial details

NCT number: NCT01281189
Sponsor: Knopp Biosciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2011-03-01
Primary completion: 2012-11-01
Enrollment: 942

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.